German biotech company BioNTech , which has approval for human trials of potential coronavirus vaccines, has lately been contacted by industry players but is not interested in a takeover, a newspaper reported on Saturday.
FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
BERLIN - BioNTech chief Ugur Sahin said the company had been approached by several players in the industry in recent weeks, Welt am Sonntag newspaper quoted him as saying, without saying what the subject of the approaches were. “Takeovers are out of the question for the majority shareholders and for us anyway. Our vision is to build a biopharmaceutical company that addresses the medical needs of the 21st century,” Sahin told the newspaper.Earlier this week, shares in BioNTech soared after Germany gave the green light for human trials of potential coronavirus vaccines it is developing with Pfizer .
BioNTech said it was developing four vaccine candidatesunder a programme with Pfizer named BNT162 in what is the fourth trial worldwide of a vaccine targeting the virus.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
German biotech firm working on COVID-19 vaccines rejects takeover approachesGerman biotech company BioNTech , which has approval for human trials of potential coronavirus vaccines, has lately received several approaches about a possible takeover but has rejected them, a newspaper reported on Saturday.
Read more »
Zara Makes Speedy, Free Deliveries of COVID-19 Medical GearThe clothing giant has delivered 457 million euros worth of sanitary medical gear to Spanish hospitals.
Read more »
First Quarter Filming in L.A. Plunges 18 Percent Due to COVID-19A new report states the obvious: The novel coronavirus had an unprecedented impact on first quarter filming in Los Angeles
Read more »
Potentially Promising Covid-19 Vaccine Hits Roadblock After Testing Reveals It’s Just ShotgunNEW BRUNSWICK, NJ—In a major setback to efforts to combat the relentless global pandemic, a potential Covid-19 vaccine from a major pharmaceutical giant reportedly hit a snag Thursday after extensive tests confirmed the once-promising method of inoculation was actually just a shotgun. “Despite very encouraging trials in which every subject who received the vaccine developed complete immunity to the novel coronavirus, further study has revealed several serious side effects, among them the fact that 100% of these participants also had their heads blown clean off,” said Johnson & Johnson CEO Alex Gorsky, explaining that the vaccine had prevented the virus from infecting any of the brain tissue or blood that was found splattered on laboratory walls, but that researchers later discovered the immunization agent had merely been a 20-gauge double-barrel shotgun. “We don’t know for certain if the firearm’s discharge is causing this severe brain damage or if the subjects were simply predisposed to such ailments, so further study is required. But it may turn out this is one of those cases where the cure is worse than the disease. Fortunately, we will soon begin human clinical trials on other possible treatments, such as jumping off bridges and ingesting huge handfuls of tranquilizers.” In his most recent press briefing, President Trump dismissed the new findings and said Americans had “nothing to lose” if they wanted to use shotguns as a preventative measure.
Read more »
Would-be autocrats are using covid-19 as an excuse to grab more powerPower-hungry leaders are treating the pandemic as an opportunity to lock-up critics, stifle opposition and increase citizen surveillance
Read more »